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 Introduction 
 Acute kidney injury (AKI) is defined as a rapid de-
crease in glomerular filtration rate (GFR) caused by both 
vascular and tubular factors, including increased renal 
vasoconstriction, loss of autoregulation and tubular ob-
struction  [1, 2] . Although incidence rates are decreasing, 
AKI is still associated with a high mortality rate. Never-
theless, the kidney has a remarkable regenerative capac-
ity and is able to recover completely after renal failure. 
Ischemia reperfusion injury is the major cause of AKI, 
and after an ischemic event different processes are in-
volved in the restoration of renal function. First, tubular 
epithelial cells have the ability to proliferate very rapidly 
and to migrate to the outer medulla where the majority 
of injury is observed  [3] . Secondary to proliferation, tu-
bular cells can dedifferentiate into a more mesenchymal 
cell type  [4] and spread to the damaged area. In addition, 
bone marrow-derived stem cells may contribute to the 
regeneration of renal damage  [5, 6] .
 Because stem cells have powerful self-renewing and 
tissue-regenerating properties they provide promising 
new therapeutic approaches for many unmet medical 
needs. Traditionally, stem cells were believed to be lin-
eage-restricted and organ-specific. However, recent stud-
ies have demonstrated that bone marrow-derived hema-
topoietic stem cells are capable of forming functional 
components of other organ tissues, like skeletal muscle 
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 Abstract 
 Acute kidney injury (AKI) is a frequent clinical problem with 
a high mortality rate, generally caused by ischemic insults. 
Nevertheless, the kidney has a remarkably high capacity to 
regenerate after ischemic injury. Tubular cells can restore re-
nal function by proliferation and dedifferentiation into a 
mesenchymal cell type, but also stem cells residing in bone 
marrow may contribute. We compiled a protocol from sev-
eral published methods to study the contribution of bone 
marrow-derived cells to renal regeneration. Bone marrow 
was isolated from donor FVB mice and labeled with en-
hanced green fluorescent protein (eGFP) through adenovi-
rus transduction. After cell sorting, eGFP-labeled cells were 
transplanted in sublethally irradiated recipient FVB mice. 
Four weeks after transplantation, we provoked AKI in mice 
by inducing unilateral ischemic-reperfusion injury for 30 
min. Seven days after the injury, eGFP-positive bone mar-
row-derived cells were clearly detectable in ischemic kidney 
tissue, and they contribute to the regeneration of approxi-
mately 10% of proximal tubular mass. In this review the ad-
vantages and shortcomings of our procedure are critically 
discussed and compared with other methods described. 
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 [7] , heart  [8] , liver  [9] and kidney  [5, 6, 10] . In addition, 
after tissue injury, differentiation of hematopoietic stem 
cells into parenchymal cells seems to be stimulated, sug-
gesting that these adult stem cells may also contribute to 
tissue repair. This review gives an overview of the tech-
niques used in mice to study the role of bone marrow-de-
rived stem cells in renal regeneration, which are summa-
rized in  table 1 . We critically compare our protocol devel-
oped for induction of acute ischemic kidney injury and 
full bone marrow cell transplantation with other pub-
lished methods in order to gain more insight into renal 
regeneration by stem cells.
 Isolation of Bone Marrow Cells and Transplantation 
 Freshly isolated bone marrow cells are used in all stud-
ies that investigate the regeneration potential of the stem 
cells they contain. We isolated full bone marrow by flush-
ing the femurs and tibiae of the donor mice with medium 
or PBS. Bone marrow can also be isolated by mincing the 
bones in very small pieces followed by collagenase treat-
ment  [11] . This procedure is likely to be equally effective 
but is more time-consuming. The isolated cells can be 
transplanted directly, or cultured and labeled prior to 
transplantation  [3, 5, 11] . In our study, isolated bone mar-
row cells were cultured and labeled with enhanced green 
fluorescent protein (eGFP). Upon culturing, it is a prereq-
uisite that cells remain in the primitive stage, which can 
be achieved by addition of several specific growth factors, 
including thrombopoietin, stem cell factor and hemato-
poiesis blockers like transforming growth factor-  . To 
prevent host-versus-graft reaction, donor mice should be 
of the same strain to exclusively study the regenerative 
capacity of the bone marrow. After transplantation, do-
nor bone marrow-derived cells have to be identified and 
discriminated from host cells. For that purpose, different 
labeling procedures have been described in the literature, 
the most effective of which are generation of chimeric 
mice (LacZ, eGFP, male/female mismatching) after trans-
plantation.
 Bone marrow transplantation can be performed with 
different  cell  populations.  We  used  full  bone marrow, 
but transplantations of the purified stem cell fraction, 
Lin – Sca-1 + c-kit + (KSL), have been described as well  [5, 
10] . The KSL markers are typical for a primitive popula-
tion of cells in the bone marrow with a high reconstitu-
tion capacity  [12, 13] . The KSL fraction can be isolated 
Table 1. Comparison of technologies used to study renal regeneration after bone marrow transplantation
Technology Isolation of bone marrow cells and
transplantation
Induction of renal ischemic injury Quantification of bone marrow-derived 
stem cells in kidney repair
Specific 
technologies
1. Labeling donor cells
2. Irradiation techniques – lethal vs. sublethal
3. Transplantation:
Full bone marrow vs. specific populationa
Time of transplantationb
1. Operation procedure – flank vs. 
midline incision
2. Clamping time 
3. Time point ischemia induction
1. Immunohistochemistry
2. Western blot analysis
3. Functional analysis
Pros 1. Detection bone marrow-derived cells
2. No or limited influence of recipient bone 
marrow cells
3. Full bone marrow contains all (supporting) 
cell populationsa – specific regenerative 
capacities can be studied
Donor bone marrow cells can ‘home’ and 
spreadb
1. Convenient methods of ischemia 
induction; – flank incisions less harmful 
for animal
2. Controlled time leads to fixed degree of 
damage
3. Directly after transplantation is less 
time-consuming
1. Direct overview of infiltrated cells in 
the kidney
2. Semiquantitative results of the 
contribution of infiltrated cells
3. Creatinine clearance and fractional 
sodium excretion are relatively simple 
and reliable tests
Cons 1. eGFP sorting procedure causes a loss of cells
2. Postoperative infections (lethal irradiation) – 
Influence recipient bone marrow prevents 
precise prediction of the stem cell regenerative 
capacity (sublethal irradiation)
3. Specific regenerative capacities are misseda
Time-consuming experimentsb
1. Midline incisions cause more often 
postoperative infections
2. Directly after transplantation causes 
higher mortality
1. False positivity is seen; additional tests 
are needed
2. False positivity, perfusion of the 
kidney is needed
3. BUN values are not reliable; additional 
tests need to be done
References 3, 5, 6, 8, 10 3, 5, 10 10, 28, 30
a, b Numbers in rows refer to technologies described in the same column.
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using fluorescence-activated cell sorting analysis, by 
means of specific markers. To minimize the influence of 
the host bone marrow, recipient mice are irradiated either 
sublethally (3.5 Gy/animal) or lethally (11–12 Gy/animal 
 [5] ). Lethal irradiation of recipient animals increases the 
risk of (postoperative) infections, but minimizes the in-
fluence of endogenous bone marrow. As a result, a more 
reliable prediction of the influence of bone marrow cells 
in the regeneration processes is obtained. However, this 
may also be achieved after sublethal irradiation of the 
mice followed by transplantation of labeled bone marrow 
cells. In addition, high irradiation doses can cause tissue 
damage and promote cell fusion, which leads to false-
positive results  [14] . After testing both methods, we pre-
ferred sublethal irradiation because of the improved 
health    condition    and   survival   rate   of   the   animals.   Af-
ter irradiation, we transplanted 1 million eGFP-labeled 
bone marrow cells in recipient animals via tail vein injec-
tion, which is the most commonly used method. The 
quantity of transplanted cells varies between 200,000 and 
5,000,000 for full bone marrow and for a KSL fraction an 
amount of 20,000–30,000 cells is often used  [5, 6, 10, 15, 
16] . An advantage of KSL-selected cells is the specificity 
of this traditional bone marrow stem cell fraction. How-
ever, other stem cell fractions with a high differentia-
tion potential, like multipotent adult progenitor cells 
(Lin – Sca-1 low c-kit – )  [17] , are excluded during KSL selec-
tion. A major advantage of using full bone marrow is that 
supporting cells are transplanted as well. This may con-
tribute to a more stable population and, eventually, a 
more successful and reliable transplantation outcome.
 Induction of Renal Ischemic Injury to Study Bone 
Marrow-Derived Stem Cell Mobilization 
 After a harmful insult, bone marrow-derived stem 
cells are mobilized to the damaged tissue where they dif-
ferentiate into a specific phenotype for regeneration  [5–8, 
18] . Renal ischemia followed by reperfusion induces AKI, 
which triggers off the mobilization of bone marrow-de-
rived stem cells. Nephrotoxicants like mercuric chloride 
(HgCl 2 )  [19] , gentamicin or cisplatin  [20–22] are occa-
sionally used to study the role of bone marrow-derived 
stem cells in renal repair. We induced AKI by applying a 
clamp on the renal artery and vein for 30 min. Prior to 
the induction of renal ischemic injury, mice were anes-
thetized with isoflurane and renal arteries and veins were 
exposed by an incision at the flank. Alternatively, a mid-
line incision through the abdomen can be made. The ex-
tent of ischemic damage is comparable for both methods; 
however, an abdominal incision increases the risk of 
complications. Moreover, postoperative pain medication 
can be minimized after a flank incision. The clamping 
time is variable and depends on the strain of mice used 
 [5, 10] . Depending on the extent of kidney injury, renal 
tubules regenerate with varying degrees of functional 
and structural recovery  [23] . Histological examinations 
are required to confirm the degree of injury after isch-
emia. The ideal time point to induce renal ischemia after 
bone marrow transplantation is rather difficult to adjust. 
Ischemia can be induced directly after irradiation and 
transplantation  [5, 10] , but also after a longer period of 
time  [3] . Inducing ischemia directly after transplantation 
and, consequently, also shortly after irradiation, is often 
associated with postoperative infections due to bone 
marrow deprivation  [5] . Obviously, this limits the trans-
plantation success. Moreover, after a longer time period 
it is expected that donor bone marrow cells move to the 
recipient bone marrow following spreading in the circu-
lation. From that point of view, cells are able to react to 
ischemic signals and migrate to the site of injury, which 
might be less stressful for the transplanted cells although 
this has not been described. In our study, AKI was in-
duced 4 weeks after bone marrow transplantation. Ani-
mal health improvement and survival rate were decisive 
for the protocol that was chosen eventually.
 Contribution of Bone Marrow-Derived Stem Cells to 
Renal Regeneration 
 For quantification of the involvement of bone mar-
row-derived stem cells in renal tissue regeneration, dif-
ferent detection methods have been described. They are 
based on either cell labeling (e.g. with LacZ, eGFP) or 
gender mismatching  [3] . These techniques have all been 
proven reliable, however, false-positive results were re-
ported for gender mismatching caused by non-specific 
binding of probe aggregates  [3, 10] . For the cell labeling it 
should be noticed that positively stained cells are all de-
rived from bone marrow but may not necessarily be la-
beled  tubular cells. These false-positive results are most 
often caused by labeled leukocytes. This can, however, be 
prevented by performing a counterstaining of leukocytes 
with anti-CD45 antibodies or by antibodies directed 
against cell-specific markers, e.g. megalin for tubular 
cells. In addition, utilization of confocal microscopy in 
the analysis of bone marrow-derived cells is recommend-
ed. A confounder of eGFP detection may be a high auto-
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fluorescence of renal cells  [24] , therefore, the use of a pri-
mary antibody directed against GFP is recommended to 
raise the fluorescent signal above background levels.
 After renal ischemic injury we observed that ap-
proximately 10% of the integral tubular segments orig-
inated from transplanted bone marrow cells, which con-
firmed the results described in other publications  [5, 10] . 
 Figure 1 is a representative image of the infiltration of 
eGFP-labeled bone marrow-derived cells 7 days after 
ischemia-reperfusion injury. This was confirmed in gen-
a b c
 Fig. 1. Infiltration of eGFP-labeled bone marrow-derived cells in 
mouse kidney before ( a ), 2 days ( b ) and 7 days ( c ) after ischemia 
induction. 2-  m cryostat sections were fixed in acetone for 10 
min and air-dried. Subsequently, kidney slices were incubated 
with the primary antibodies against eGFP (Roche Diagnostics, 
Basel, Switzerland) diluted 1: 200, or Ter-119/Ly-76 (Becton Dick-
inson, Breda, The Netherlands), a marker for erythrocytes, di-
luted 1: 200. Next, slices were washed 3 times and incubated with 
the secondary antibody; goat anti-rabbit Alexa Fluo 488 was used 
for eGFP (green staining) or goat anti-rat Alexa Fluo 594 for Ter-
119/Ly-76 (red staining; both secondary antibodies obtained from 
Invitrogen, Breda, The Netherlands). Stained sections were exam-
ined using a confocal laser-scanning microscope (Leica Laser-
technik GmbH, Heidelberg, Germany). 200 ! . 
a b
 Fig. 2. Ischemic kidney injury recruits bone marrow-derived cells 
to renal tubules in gender-mismatched chimeras. After the trans-
plantation of female bone marrow (XX) into male recipient (XY) 
mice, only XY cells were found and engraftment of female donor 
mice bone marrow cells in the recipient male kidney seems neg-
ligible 4 weeks after bone marrow transplantation before ischemic 
injury ( a ). However, 7 days postischemia, infiltration of XX-posi-
tive cells (indicated with arrow) in the male kidney was observed 
( b ). Fluorescence in situ hybridization was performed using a 
mouse whole chromosome X paint (FITC, green) and Y (Cy3, red) 
(Cambio, Sanbio BV, Uden, The Netherlands). To this end, kid-
neys were perfused prior to isolation and snap-freezing in liquid 
nitrogen. 2-  m cryostat sections were pretreated with pepsin 
(Sigma-Aldrich, Zwijndrecht, The Netherlands), prefixed in 70% 
ethanol –20 ° C, washed with Nonidet P40 (Sigma) and dehydrat-
ed. Of each chromosome paint, 3   l was used in a total of 10   l 
hybridization mix (Cambio) and administered under a coverslip 
of 20  ! 20 mm and denatured simultaneously on a Hybaid Om-
nislide (Thermo Electron, Breda, The Netherlands). Posthybrid-
ization was performed by a wash step of 0.4  ! SSC/Tween-20
at 68.5 ° C (1  ! SSC is 0.15  M sodium chloride/0.015  M sodium 
 citrate) followed by several steps of 2  ! SSC, 4  ! SSC and PBS at 
room temperature. After dehydration the slides were hybridized 
with fluorescent probes to detect Y- and X-chromosomes, and 
counterstained with DAPI (blue) to show nuclei. A Zeiss Axio-
phot-2 microscope equipped with appropriate fluorescence filters 
was used for analysis of the fluorescence signals. Images were cap-
tured by Leica DC 350FX camera using a Leica CW4000 software 
package. 630 ! . 
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der-mismatched chimeras in which bone marrow-de-
rived cells were recruited to renal tubules ( fig. 2 ). In ac-
cordance with Li et al.  [25] , fusion of stem cells with so-
matic cells does not account for the majority of the 
conversion of bone marrow cells to renal cells after isch-
emic injury. Western blot analysis can be used to quan-
tify the amount of eGFP-positive bone marrow-derived 
cells in the kidney. A critical note, however, is that West-
ern blot analysis can only differentiate between eGFP/
LacZ  expression in tubular cells or in leukocytes when 
the kidney is perfused before isolation. Inflammatory 
processes often play a significant role in the pathophysi-
ology of AKI causing, among others, outer medullary 
congestion  [2] . Consequently, erythrocytes stick to the 
outer medulla, which hampers the perfusion procedure. 
In addition, attention should be paid to single tubular-
like cells derived from the transplanted bone marrow, be-
cause these cells may also originate from donor leuko-
cytes that fuse with residing tubular cells. To overcome 
these limitations, different identification techniques 
should be employed to confirm the findings.
 Renal function tests are required to determine the out-
come of the regeneration process. The most common 
functional parameters used are creatinine clearance and 
blood urea nitrogen (BUN) concentration  [5, 26] . Creati-
nine clearance is a widely accepted parameter for GFR 
assessment, although one should be cautious for misin-
terpretations caused by inadequate urine collection and 
differences in creatinine production. A decreased creati-
nine clearance accompanied by an unchanged serum cre-
atinine concentration can be caused by inadequate urine 
collection. In addition, production of creatinine differs 
among and within individuals over time, depending on 
dietary intake (vegetarian diet, creatine supplements) or 
muscle mass. In this case, determinations of the renal 
clearance of inulin or other exogenous compounds, such 
as iothalamate, iohexol, or DTPA, are more reliable mark-
ers of GFR  [27–29] . Individual variations in mice are, 
however, easy to exclude by using control animals which 
are genetically identical and are housed under the same 
conditions. Using our research protocol, a decreased cre-
atinine clearance was observed 2 days after the induction 
of ischemia (p  ! 0.001), which returned to near normal 
levels on day 7 postischemia (data not shown).
 The BUN concentration, on the other hand, is not as 
reliable as creatinine clearance, because it can vary inde-
pendently of GFR changes due to variations in the rate of 
urea production. For example, a high protein diet results 
in an increase in BUN, as does enhanced tissue break-
down due to hemorrhage, trauma or corticosteroids. 
Whenever BUN values are used to predict renal function, 
additional tests, like creatinine clearance or fractional so-
dium excretion, should be performed to get a more reli-
able assessment of renal function.
 Conclusions 
 Considerable progress has been made in the develop-
ment of different techniques to study the role of bone 
marrow-derived stem cells in ischemia-induced AKI. Us-
ing the method described in this review, we have shown 
that at least 10% of the regenerated proximal tubular seg-
ments originate from donor bone marrow. However, con-
troversial results have been reported in the literature, 
mainly originating from differences in experimental 
models. We have listed the currently available techniques 
in  table 1 to aid in the selection of the most appropriate 
experimental model. Bone marrow consists of several 
stem cell populations and the specific types responsible 
for regeneration of damaged kidney tissue are still not 
known. It is likely that more subpopulations are respon-
sible for this process, but their contribution has yet to be 
investigated by transplantation of the purified fractions.
 To study the regeneration process in vivo, mice should 
be in a good health condition to prevent the influence of 
other confounding factors. To achieve this, AKI should 
not be induced sooner than a few weeks after transplan-
tation. In addition to a better physical condition of the 
recipient mice, a longer period between transplantation 
and injury induction is also beneficial for the regenera-
tion process. Moreover, a longer time period allows cells 
to spread and migrate in the circulation, and to reconsti-
tute the bone marrow.
 Finally, to assess the overall contribution of bone mar-
row-derived stem cells in kidney regeneration, several 
methods can be applied, of which immunohistochemis-
try is the most reliable technique. An important issue is 
the exclusion of false-positive cells. The use of confocal 
microscopy and (double) staining of the kidney samples 
in quantitative analysis and the gender-mismatching 
procedure in donor and recipient mice reduces the chance 
of false-positive results. The outcome of kidney renewal 
after acute injury can be investigated by several function-
al tests. Although these tests do not cover the contribu-
tion of bone marrow cells, they give detailed information 
about the progression of the regeneration process and 
help in the comparison of different protocols.
 The use of appropriate in vivo models accompanied 
with more in vitro data about the differentiation process 
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